Loading organizations...
Growth Fund, based in Sydney, New South Wales, Australia, invests in successful businesses across Australia and New Zealand, partnering with founders and management teams to provide growth capital for strategic initiatives. The firm supports expansion, product development, mergers, acquisitions, and succession planning, targeting companies with an enterprise value up to $200 million. Growth Fund maintains an industry-agnostic approach, excluding property and direct commodities, and typically acquires minority stakes. It operates with fewer than 25 employees and generates under $5 million in revenue. A related entity, ABGF, was established with $540 million in initial capital, employing a public-private partnership model and investing $5-15 million per deal in businesses with $2-100 million revenue. Specific lead investors, portfolio companies, or founding details for Growth Fund are not publicly known.
Growth Fund has 2 tracked investments across 2 companies. The latest tracked deal is $50.0M Series B in InxMed in March 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 4, 2022 | InxMed | $50.0M Series B | HUA YI | Aihc Capital, Hosencare Fund |
| Jul 7, 2021 | Aleph Farms | $105.0M Series B | Mayank Singhal, Growth Fund | Lorival LUZ, Cargill, CPT Capital, Peregrine Ventures, Skyviews Life Science, Strauss Group, Thiraphong Chansiri, VisVires NEW Protein |